Rosemary D Cress1, Yingjia S Chen, Cyllene R Morris, Megan Petersen, Gary S Leiserowitz. 1. Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, and the Cancer Registry of Greater California, Public Health Institute, the California Cancer Reporting and Epidemiologic Surveillance (CalCARES) Program, Institute for Population Health Improvement, University of California Davis Health System, and the Division of Gynecologic Oncology, University of California Davis Medical Center, Sacramento, California.
Abstract
OBJECTIVE: To identify characteristics associated with long-term survival for patients with epithelial ovarian cancer using the California Cancer Registry. METHODS: A descriptive analysis of survival of all California residents diagnosed with epithelial ovarian cancer between 1994 and 2001 was conducted using patients identified through the cancer registry with follow-up through 2011. Characteristics of the patients who survived more than 10 years (long-term survivors) were compared with three other cohorts: patients who survived less than 2 years, those who survived at least 2 but no more than 5 years, and those who survived at least 5 but no more than 10 years. RESULTS: A total of 3,582 out of 11,541 (31%, confidence interval 30.2-31.8%) of the patients survived more than 10 years. Younger age, early stage, low-grade, and nonserous histology were significant predictors of long-term survival, but long-term survivors also included women with high-risk cancer. CONCLUSION: Long-term survival is not unusual in patients with epithelial ovarian cancer, even in those with high-risk disease. Many of the prognostic factors are well known, but it remains to be determined why some patients with advanced-stage high-grade cancers survive longer than others with the same histology. These findings are important for patient counseling. LEVEL OF EVIDENCE: III.
OBJECTIVE: To identify characteristics associated with long-term survival for patients with epithelial ovarian cancer using the California Cancer Registry. METHODS: A descriptive analysis of survival of all California residents diagnosed with epithelial ovarian cancer between 1994 and 2001 was conducted using patients identified through the cancer registry with follow-up through 2011. Characteristics of the patients who survived more than 10 years (long-term survivors) were compared with three other cohorts: patients who survived less than 2 years, those who survived at least 2 but no more than 5 years, and those who survived at least 5 but no more than 10 years. RESULTS: A total of 3,582 out of 11,541 (31%, confidence interval 30.2-31.8%) of the patients survived more than 10 years. Younger age, early stage, low-grade, and nonserous histology were significant predictors of long-term survival, but long-term survivors also included women with high-risk cancer. CONCLUSION: Long-term survival is not unusual in patients with epithelial ovarian cancer, even in those with high-risk disease. Many of the prognostic factors are well known, but it remains to be determined why some patients with advanced-stage high-grade cancers survive longer than others with the same histology. These findings are important for patient counseling. LEVEL OF EVIDENCE: III.
Authors: Christina L Clarke; Lawrence H Kushi; Jessica Chubak; Pamala A Pawloski; Joanna E Bulkley; Mara M Epstein; Andrea N Burnett-Hartman; Bethan Powell; Celeste L Pearce; Heather Spencer Feigelson Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-04-09 Impact factor: 4.254
Authors: Kathleen N Moore; Austin Miller; Katherine M Bell-McGuinn; Russell J Schilder; Joan L Walker; Roisin E O'Cearbhaill; Saketh R Guntupalli; Deborah K Armstrong; Andrea R Hagemann; Heidi J Gray; Linda R Duska; Cara A Mathews; Alice Chen; David O'Malley; Sarah Gordon; Paula M Fracasso; Carol Aghajanian Journal: Gynecol Oncol Date: 2019-11-07 Impact factor: 5.482
Authors: Sherri L Stewart; Rhea Harewood; Melissa Matz; Sun Hee Rim; Susan A Sabatino; Kevin C Ward; Hannah K Weir Journal: Cancer Date: 2017-12-15 Impact factor: 6.860
Authors: Peter G Rose; James J Java; Ritu Salani; Melissa A Geller; Angeles Alvarez Secord; Krishnansu S Tewari; David P Bender; David G Mutch; Michael L Friedlander; Linda Van Le; Michael W Method; Chad A Hamilton; Roger B Lee; Robert M Wenham; Saketh R Guntupalli; Maurie Markman; Franco M Muggia; Deborah K Armstrong; Michael A Bookman; Robert A Burger; Larry J Copeland Journal: Obstet Gynecol Date: 2019-02 Impact factor: 7.661